CFAP221: A Potential Drug Target Or Biomarker (G200373)

Target Name: CFAP221

NCBI ID: G200373

CFAP221

CFAP221: A Potential Drug Target Or Biomarker

CFAP221 (PCDP1), a protein that belongs to the C-type water-binding protein (CWBP) family, has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to investigate, and its potential as a drug or biomarker has generated a lot of interest in the scientific community.

CFAP221 is a 194-kDa protein that is expressed in various tissues and organs, including brain, heart, lungs, liver, and pancreas. It is a member of the CWBP family, which includes other proteins that are known for their ability to interact with water and play a role in various physiological processes, including cell signaling, tissue repair, and inflammation.

One of the unique features of CFAP221 is its ability to form inclusion bodies in cells. Inclusion bodies are structures that can be derived from various proteins, including CFAP221. These structures are typically formed when proteins interact with each other and cause the formation of a complex that is not soluble in water. The inclusion bodies that are formed by CFAP221 can be either monomeric or dimeric, and they have been shown to play a role in various cellular processes, including cell signaling, protein-protein interactions, and intracellular signaling.

CFAP221 has also been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and invasion. It is a co-factor of the protein PDGF-A, which is a well-known transcription factor that plays a role in regulating cell proliferation, differentiation, and survival. The interaction between CFAP221 and PDGF-A has been shown to play a role in the regulation of various cellular processes, including the growth and differentiation of tissues and organs.

CFAP221 has also been shown to be involved in the regulation of inflammation. It is a co-factor of the protein NF-kappa-B, which is a well-known transcription factor that plays a role in the regulation of inflammation and immune responses. The interaction between CFAP221 and NF-kappa-B has been shown to play a role in the regulation of various cellular processes, including inflammation, immune cell function, and cell survival.

CFAP221 has also been shown to be involved in the regulation of cellular signaling pathways. It is a co-factor of the protein T-cell factor (TGF-1), which is a well-known transcription factor that plays a role in regulating cellular signaling pathways, including cell proliferation, differentiation, and survival. The interaction between CFAP221 and TGF-1 has been shown to play a role in the regulation of various cellular processes, including the regulation of cell signaling pathways.

CFAP221 has also been shown to be involved in the regulation of tissue repair and regeneration. It is a co-factor of the protein PLA2, which is a well-known transcription factor that plays a role in the regulation of tissue repair and regeneration. The interaction between CFAP221 and PLA2 has been shown to play a role in the regulation of various cellular processes, including tissue repair and regeneration.

CFAP221 has also been shown to be involved in the regulation of various signaling pathways. It is a co-factor of the protein NF-kappa-B, which is a well-known transcription factor that plays a role in the regulation of inflammation and immune responses. The interaction between CFAP221 and NF-kappa-B has been shown to play a role in the regulation of various cellular processes, including the regulation of inflammation and immune cell function.

In conclusion, CFAP221 is a protein that has been identified as a potential drug target or biomarker for various diseases. Its unique structure and function have made it an attractive target for researchers to investigate, and its potential as a drug or biomarker has generated a lot of interest in the scientific community. Further research is needed to fully understand the role of CFAP221 in various cellular processes and its potential as a drug or biomarker.

Protein Name: Cilia And Flagella Associated Protein 221

Functions: May play a role in cilium morphogenesis

The "CFAP221 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFAP221 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets